Current Edition

news

Lupin, Mylan to commercialize Enbrel Biosimilar

Under the terms of the agreement, Lupin will receive an up-front payment of $15 million. Pharma major Lupin Limited and global pharmaceutical company Mylan have …

Continue Reading →
news

Pfizer Receives CRL for Biosimilar to Roche’s Herceptin

On April 23, 2018, Pfizer announced that it received a complete response letter (CRL) from FDA in response to the biologics license application (BLA) for …

Continue Reading →